Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yupei Zhao

Showing results (161-170 of 297) with videos related to

Pageof 30
Sort By:
Pancreas|June 14, 2016
The Effect of Body Mass Index on Surgical Outcomes in Patients Undergoing Pancreatic Resection: A Systematic Review and Meta-AnalysisLei You, Wenjing Zhao, Xiafei Hong, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
THE INFLUENCE OF SURGICAL EXTENT AND PARAFIBROMIN STAINING ON THE OUTCOME OF PARATHYROID CARCINOMA: 20-YEAR EXPERIENCE FROM A SINGLE INSTITUTEYa Hu, Yalan Bi, Ming Cui, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 17, 2016
Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophagesQiaofei Liu, Yuan Li, Zheyu Niu, et al.
Medicine|March 28, 2015
Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markersWenming Wu, Xiafei Hong, Ji Li, et al.
Annals of Surgical Oncology|October 18, 2013
High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinomaZhang Wen, Quan Liao, Jianguo Zhao, et al.
Cancer Cell International|June 6, 2021
Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancerYuan Chen, Ruiyuan Xu, Rexiati Ruze, et al.
Cancer Letters|July 3, 2021
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosisJie Cai, Hongda Chen, Ming Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2023
Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modificationsJinshou Yang, Bo Ren, Jie Ren, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 21, 2014
[Comparison of open preperitoneal repair and Lichtenstein herniorraphy on the surgical treatment of inguinal hernia]Ziwen Liu, Mengqing Sun, Liyang Zhang, et al.
Molecular Cancer|January 7, 2018
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applicationsJiangdong Qiu, Gang Yang, Mengyu Feng, et al.
Pageof 30

Showing results (161-170 of 297) with videos related to

Sort By:
Pageof 30
Pancreas|June 14, 2016
The Effect of Body Mass Index on Surgical Outcomes in Patients Undergoing Pancreatic Resection: A Systematic Review and Meta-AnalysisLei You, Wenjing Zhao, Xiafei Hong, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 14, 2019
THE INFLUENCE OF SURGICAL EXTENT AND PARAFIBROMIN STAINING ON THE OUTCOME OF PARATHYROID CARCINOMA: 20-YEAR EXPERIENCE FROM A SINGLE INSTITUTEYa Hu, Yalan Bi, Ming Cui, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 17, 2016
Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophagesQiaofei Liu, Yuan Li, Zheyu Niu, et al.
Medicine|March 28, 2015
Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markersWenming Wu, Xiafei Hong, Ji Li, et al.
Annals of Surgical Oncology|October 18, 2013
High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinomaZhang Wen, Quan Liao, Jianguo Zhao, et al.
Cancer Cell International|June 6, 2021
Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancerYuan Chen, Ruiyuan Xu, Rexiati Ruze, et al.
Cancer Letters|July 3, 2021
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosisJie Cai, Hongda Chen, Ming Lu, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 27, 2023
Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modificationsJinshou Yang, Bo Ren, Jie Ren, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|November 21, 2014
[Comparison of open preperitoneal repair and Lichtenstein herniorraphy on the surgical treatment of inguinal hernia]Ziwen Liu, Mengqing Sun, Liyang Zhang, et al.
Molecular Cancer|January 7, 2018
Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applicationsJiangdong Qiu, Gang Yang, Mengyu Feng, et al.
Pageof 30